Joseph Michael Burnett net worth and biography

Joseph Burnett Biography and Net Worth

CEO of ClearPoint Neuro

Joe joined ClearPoint Neuro in November 2017. He was previously the Vice President & General Manager of Neuro Diagnostics and Therapy at Philips, starting in March 2016. Prior to that, Joe served as the Senior Vice President and Business Leader of Image Guided Therapy Devices at Philips from February 2015 to March 2016 after it acquired Volcano Corporation. Before Philips’ acquisition of Volcano in February 2015, he held various positions at Volcano from November 2004 to February 2015, most recently as Executive Vice President & General Manager of its Coronary & Systems Business Unit. He holds an MBA from the Fuqua School of Business at Duke University and a B.S.E. degree in Biomedical Engineering from Duke University.

What is Joseph Michael Burnett's net worth?: The estimated net worth of Joseph Michael Burnett is at least $3.51 million as of August 15th, 2022. Mr. Burnett owns 262,095 shares of ClearPoint Neuro stock worth more than $3,506,831 as of November 7th. This net worth evaluation does not reflect any other investments that Mr. Burnett may own. Additionally, Mr. Burnett receives an annual salary of $803,120.00 as CEO at ClearPoint Neuro. Learn More about Joseph Michael Burnett's net worth.
How old is Joseph Michael Burnett?: Mr. Burnett is currently 47 years old. There are 3 older executives and no younger executives at ClearPoint Neuro. Learn More on Joseph Michael Burnett's age.
What is Joseph Michael Burnett's salary?: As the CEO of ClearPoint Neuro, Inc., Mr. Burnett earns $803,120.00 per year. Learn More on Joseph Michael Burnett's salary.
How do I contact Joseph Michael Burnett?: The corporate mailing address for Mr. Burnett and other ClearPoint Neuro executives is 5 MUSICK, IRVINE CA, 92618. ClearPoint Neuro can also be reached via phone at (949) 900-6833 and via email at [email protected]. Learn More on Joseph Michael Burnett's contact information.
Has Joseph Michael Burnett been buying or selling shares of ClearPoint Neuro?: Joseph Michael Burnett has not been actively trading shares of ClearPoint Neuro during the past quarter. Most recently, Joseph Michael Burnett sold 18,867 shares of the business's stock in a transaction on Monday, August 15th. The shares were sold at an average price of $16.07, for a transaction totalling $303,192.69. Following the completion of the sale, the chief executive officer now directly owns 262,095 shares of the company's stock, valued at $4,211,866.65. Learn More on Joseph Michael Burnett's trading history.

Joseph Michael Burnett Insider Trading History at ClearPoint Neuro

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/15/2022	Sell	18,867	$16.07	$303,192.69	262,095
11/11/2021	Sell	10,000	$16.88	$168,800.00
9/21/2021	Sell	9,637	$17.98	$173,273.26
6/21/2021	Sell	25,000	$18.57	$464,250.00	237,366

Joseph Michael Burnett Buying and Selling Activity at ClearPoint Neuro

ClearPoint Neuro Company Overview

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Today's Range

Now: $13.38

$12.74

$13.40

50 Day Range

MA: $12.15

$10.80

$13.46

2 Week Range

Now: $13.38

$4.05

$14.13

Volume

348,735 shs

Average Volume

228,433 shs

Market Capitalization

$369.29 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.1

Watch this before it gets removed

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.